dichloroacetic acid has been researched along with px 478 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danker, K; Eickholt, B; Klein, A; Parczyk, J; Ruhnau, J | 1 |
| Danker, K; Eickholt, B; Klein, A; Kühn, H; Parczyk, J; Pelz, C; Piaskowski, NN; Ruhnau, J; Schilling, M; Wu, H | 1 |
2 other study(ies) available for dichloroacetic acid and px 478
| Article | Year |
|---|---|
Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Dichloroacetic Acid; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; L-Lactate Dehydrogenase; Mustard Compounds; Phenylpropionates; Piperazines; Proto-Oncogene Proteins c-mdm2; Pyruvate Dehydrogenase Complex; Reproducibility of Results | 2020 |
Dichloroacetate and PX-478 exhibit strong synergistic effects in a various number of cancer cell lines.
Topics: A549 Cells; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dichloroacetic Acid; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; HeLa Cells; HT29 Cells; Humans; MCF-7 Cells; Mustard Compounds; Phenylpropionates; Reactive Oxygen Species | 2021 |